Metamark will combine its multiplex protein detection platform with image analysis technology developed jointly with Definiens to develop prognostic and predictive assays for early-stage cancers

Definiens AG

Germany / Tools, Services, and Manufacturing

Licensor

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Metamark Genetics Inc.

U.S. / Medical Devices and Diagnostics

Licensee

This is a sample profile. To view the full content of this profile and many others, log in to BCIQ or sign up for a free trial today!

Active

Sample

01/01/2009

announced